A Study to Evaluate the Efficacy and Safety of Co-administration of AD-227A and AD-227B

A Multicenter, Randomized, Double-blind, Phase III Study to Evaluate the Efficacy and Safety of AD-227A and AD-227B Combination Treatment in Patients with Essential Hypertension

The purpose of this study is to evaluate the efficacy and safety of co-administration of AD-227A and AD-227B in patients with essential hypertension

Essential Hypertension

Inclusion Criteria:

• Signed informed consent
• Patients with Essential Hypertension
• Other inclusions applied

Exclusion Criteria:

• Patient with Secondary Hypertension
• Other exclusions applied